Sagar Uttarkar

717 total citations
8 papers, 550 citations indexed

About

Sagar Uttarkar is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Sagar Uttarkar has authored 8 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Oncology. Recurrent topics in Sagar Uttarkar's work include Histone Deacetylase Inhibitors Research (3 papers), Acute Myeloid Leukemia Research (2 papers) and Cell death mechanisms and regulation (2 papers). Sagar Uttarkar is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Acute Myeloid Leukemia Research (2 papers) and Cell death mechanisms and regulation (2 papers). Sagar Uttarkar collaborates with scholars based in Germany, United Kingdom and Switzerland. Sagar Uttarkar's co-authors include Karl‐Heinz Klempnauer, Martin Philpott, S. Picaud, Tom D. Heightman, Stefan Knapp, O. Fedorov, P. Filippakopoulos, Jon Frampton, Joachim Jose and Chaitanya Vuppusetty and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and Journal of Medicinal Chemistry.

In The Last Decade

Sagar Uttarkar

8 papers receiving 543 citations

Peers

Countries citing papers authored by Sagar Uttarkar

Since Specialization

Citations

This map shows the geographic impact of Sagar Uttarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sagar Uttarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sagar Uttarkar more than expected).

Fields of papers citing papers by Sagar Uttarkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sagar Uttarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sagar Uttarkar. The network helps show where Sagar Uttarkar may publish in the future.

Co-authorship network of co-authors of Sagar Uttarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Sagar Uttarkar. A scholar is included among the top collaborators of Sagar Uttarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sagar Uttarkar. Sagar Uttarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Regulatory cells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapies 2019 ·Journal of Allergy and Clinical Immunology ·Sagar Uttarkar, Nicolò Costantino Brembilla, Wolf‐Henning Boehncke	35
2	Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C/EBPβ 2017 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Kim D. Falkenberg, (unknown), (unknown), Wolfgang Dörner, Sagar Uttarkar, (unknown), (unknown), (unknown), (unknown), Henning D. Mootz, Thomas J. Schmidt, Karl‐Heinz Klempnauer	23
3	Targeting the transcription factor Myb by small-molecule inhibitors 2016 ·Experimental Hematology ·Sagar Uttarkar, Jon Frampton, Karl‐Heinz Klempnauer	38
4	Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells 2016 ·Molecular Cancer Therapeutics ·Sagar Uttarkar, (unknown), (unknown), (unknown), Peter Schlenke, Wolfgang E. Berdel, Carsten Müller‐Tidow, Thomas J. Schmidt, Karl‐Heinz Klempnauer	41
5	Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300 2015 ·Molecular Cancer Therapeutics ·Sagar Uttarkar, (unknown), (unknown), Michael Goblirsch, Joachim Jose, Karl‐Heinz Klempnauer	54
6	Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction 2015 ·Blood ·Sagar Uttarkar, Emilie Dassé, (unknown), (unknown), (unknown), (unknown), (unknown), Joachim Jose, Peter Schlenke, Wolfgang E. Berdel, Thomas J. Schmidt, Carsten Müller‐Tidow, Jon Frampton, Karl‐Heinz Klempnauer	80
7	Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery 2011 ·Molecular BioSystems ·Martin Philpott, Jing Yang, (unknown), O. Fedorov, Sagar Uttarkar, P. Filippakopoulos, S. Picaud, Tracy Keates, I. Felletar, Alessio Ciulli, Stefan Knapp, Tom D. Heightman	107
8	3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands 2011 ·Journal of Medicinal Chemistry ·David S. Hewings, Minghua Wang, Martin Philpott, O. Fedorov, Sagar Uttarkar, P. Filippakopoulos, S. Picaud, Chaitanya Vuppusetty, Brian D. Marsden, Stefan Knapp, Stuart J. Conway, Tom D. Heightman	172

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact